Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Step by step instructions to Pick the Right Dental specialist for Your Dental Inserts Technique - 2This Canadian crater looks like marbled meat | Space photo of the day for Jan. 6, 2026
- 3New Jordan security fence could be done in early 2028
- 4Viable Correspondence: Building Solid Connections
- 5The Most Compelling Books of the 10 years
- Misinterpretations and Mistakes Portrayed by Hollywood in the General set of laws
- New studies of old dogs help scientists understand where they came from
- How did this 20-light-year-wide 'Diamond Ring' form in space? Maybe a cosmic bubble burst
- To fix a patient's irregular heartbeat, doctors first tested its digital 'twin'
- Book excerpt: "Eat Your Ice Cream" by Ezekiel J. Emanuel, M.D.
- Dominating the Remote Work Way of life: Individual Systems
- Some super-smart dogs can pick up new words just by eavesdropping
- Compassion and Association: Building Significant Connections
- This Underrated Italian City Boasts Indulgent Food & Captivating Views For A Romantic Escape
